CAS RN: 1301190-20-4
N,N-Dimethyl-N’-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]sulfamide
Product Availability
Choose a grade to view its available package options.
1 package records1 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20250131 |
250mg / 1g |
Confirm by inquiry |
Shanghai | Inquiry |
GET A QUOTE
1301190-20-4 / 2-[3-(dimethylsulfamoylamino)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Standard CAS: 1301190-20-4
Multi CAS: No
Basic Information
CAS
1301190-20-4
Multi CAS
No
Molecular Formula
C14H23BN2O4S
Molecular Weight
326.200000
Exact Mass
326.147159
SMILES
B1(OC(C(O1)(C)C)(C)C)C2=CC(=CC=C2)NS(=O)(=O)N(C)C
InChI
InChI=1S/C14H23BN2O4S/c1-13(2)14(3,4)21-15(20-13)11-8-7-9-12(10-11)16-22(18,19)17(5)6/h7-10,16H,1-6H3
InChIKey
WTSUHCHNMIUEFJ-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
22
Aromatic heavy atom count
6
Fraction Csp3
0.57
Rotatable bonds
4
H-bond acceptors
4
H-bond donors
1
Molar refractivity
88.39
TPSA
67.87
LogP / Solubility
WLOGP
1.2
MLOGP
1.07
XLogP3
1.2
Consensus LogP
1.16
Log S (ESOL)
-2.56
Class (ESOL)
Moderately soluble
Log S (Ali)
-3.1
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-3.26
Class (SILICOS-IT)
Poorly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.86
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
Yes
Synthetic Accessibility
2.5